A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study

Richard Hobbs(John Radcliffe Hospital), Gregory Y.H. Lip(University of Liverpool)

Health Technology Assessment

October 1, 2005

10.3310/hta9400

Cited by 432

Related Papers

Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007–14

|The Lancet|2016|627

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

|BMJ|2016|442

Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES)

|European Heart Journal|2007|218

Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations

|Heart|2004|69

Microparticles and cardiovascular diseases

|Annals of Medicine|2019|54